Cross Country Healthcare faces sharply declining revenue, falling analyst estimates, a rich valuation relative to its earnings power, and a consistent pattern of earnings misses -- a confluence of factors that keeps quality below the engine's floor and supports the exit signal.
Thesis pillars
- Sharply Declining Revenue→Stable
- Falling Estimates Sentiment Deterioration→Stable
- Rich Valuation Vs Earnings Power→Stable
- +1 more pillar — see the Why tab for full reasoning
Cross Country Healthcare, Inc. (CCRN) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $13.20: Quality below floor (2.2 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.4/10. Specifically: Below-average business quality; Rich valuation; Negative price momentum.
Cross Country Healthcare, Inc. is a healthcare workforce solutions company providing travel and per diem staffing for nurses, allied health professionals, physicians, and education specialists across two segments — Nursing and Allied Staffing and Physician Staffing — powered by... Read more
Sell if holding. Engine safety override at $13.20: Quality below floor (2.2 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.4/10. Specifically: Below-average business quality; Rich valuation; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Score 3.4/10, high confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 31d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
About Cross Country Healthcare, Inc.
About Cross Country Healthcare, Inc.
Cross Country Healthcare places travel and per diem nurses, allied health professionals, physicians, and education specialists through two segments — Nursing and Allied Staffing and Physician Staffing — across all 50 states, with the largest share of 2025 revenue concentrated in California, Florida, and New York. The company competes in an estimated $39.4 billion U.S. healthcare staffing market, and on December 4, 2025 its pending acquisition by Aya Healthcare terminated, yielding a $20.0 million termination fee.
Revenue comes primarily from staffing registered nurses and allied professionals on roughly 13-week travel contract assignments at hospitals and health systems, supplemented by managed service program (MSP) administrative fees, Physician Staffing placements lasting days to a year, and Cross Country Education's school-based staffing. Healthcare professionals are Cross Country employees paid hourly with benefits including housing and travel reimbursement, while Physician Staffing largely uses independent contractors; customer contracts are typically cancelable on 30 to 90 days' notice, and no single customer accounted for more than 10% of revenue in 2025, 2024, or 2023. The company runs significant back-office information-systems, finance, and accounting functions through its Cross Country Infotech subsidiary in India, concentrating those critical functions in a single country outside the U.S. In December 2025, CEO John Martins separated from the company and Chairman and co-founder Kevin Clark, CEO from 2019 to 2022, returned as President and CEO effective December 15, 2025.
Show full overview
Cross Country's near-term execution risk centers on a compressed leadership reset rather than a single clinical or reimbursement lever: the Aya Healthcare acquisition — under a signed merger agreement since December 2024 — lapsed at its outside date in December 2025 rather than closing, and within the same two-week window the company also changed chief executives, naming board chairman and former CEO Kevin Clark to the role his predecessor had held. The 10-K itself flags that leadership transitions of this nature can disrupt strategic initiatives and organizational stability, layering management-continuity risk on top of a travel-nurse segment that the industry's own trade data show contracting for a third consecutive year before an expected slight recovery in 2026.
See also: Healthcare · Medical Care Facilities
From Cross Country Healthcare, Inc.'s most recent 10-K filing, extracted July 6, 2026.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
5 floor-breakers
Revenue shrinking — -17.8% YoY. Growth thesis broken unless recovery story develops.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Unprofitable operations — net margin -9.8%. Quality floor flags this regardless of sector context.static
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $13.20: Quality below floor (2.2 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 3.4/10. Specifically: Below-average business quality; Rich valuation; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $13.14. Score 3.4/10, high confidence.
Take-profit target: $12.97 (-1.7% upside). Prior stop was $13.14. Stop-loss: $13.14.
Target reached (-17.0% upside); Quality below floor (2.2 < 4.0).
Cross Country Healthcare, Inc. trades at a P/E of N/A (forward 47.1). TrendMatrix value score: 3.6/10. Verdict: Sell.
14 analysts cover CCRN with a consensus score of 2.6/5. Average price target: $13.
What does Cross Country Healthcare, Inc. do?Cross Country Healthcare, Inc. is a healthcare workforce solutions company providing travel and per diem staffing for...
Cross Country Healthcare, Inc. is a healthcare workforce solutions company providing travel and per diem staffing for nurses, allied health professionals, physicians, and education specialists across two segments — Nursing and Allied Staffing and Physician Staffing — powered by its Intellify vendor management platform. The company operates in all 50 states with the largest share of 2025 revenue concentrated in California, Florida, and New York, and in December 2025 it terminated a pending acquisition by Aya Healthcare (collecting a $20.0 million termination fee) while transitioning CEO John Ma